"
Team:Tufts/future
From 2014.igem.org
(Difference between revisions)
| Line 11: | Line 11: | ||
This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy. | This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy. | ||
<br><br> | <br><br> | ||
| - | The conference incorporated two main events. The first a discussion between experts, held | + | The conference incorporated two main events. The first was a discussion between experts, held |
under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage | under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage | ||
| - | + | applications and associated safety and regulatory considerations. This was followed by a public | |
forum to present and discuss the results and implications with a more general audience before | forum to present and discuss the results and implications with a more general audience before | ||
shifting to guided and informal discussion. | shifting to guided and informal discussion. | ||
Latest revision as of 03:46, 18 October 2014
This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy.
The conference incorporated two main events. The first was a discussion between experts, held under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage applications and associated safety and regulatory considerations. This was followed by a public forum to present and discuss the results and implications with a more general audience before shifting to guided and informal discussion.
The conference incorporated two main events. The first was a discussion between experts, held under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage applications and associated safety and regulatory considerations. This was followed by a public forum to present and discuss the results and implications with a more general audience before shifting to guided and informal discussion.
